Multiple sclerosis linked to higher risk of mental illness during and after pregnancy
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births in Ontario.
Women With Multiple Sclerosis Show Increased Migraine Risk Before Symptom Onset
Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk for migraine for up to a decade prior to MS symptom onset, according to study results published in The Journal of Headache and Pain.
New Study Links Multiple Sclerosis to Increased Mental Health Risks During and After Pregnancy
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during pregnancy and the first year after childbirth, compared to those without MS.
Pregnancy raises risks to mental health in MS patients, study says
Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.
Mental health risks higher for pregnant people with MS
Pregnant people with multiple sclerosis (MS) have a higher chance of experiencing mental illness both during their pregnancy and in the first years after they give birth than those without MS, according to a study published in the January 22,
Pregnancy Increases Mental Health Risk in MS Patients
Pregnancy increases the risk of mental illness among women with multiple sclerosis (MS). Pregnant MS patients have a higher risk of mental illness both during gestation and in the first years after they give birth,
GlobalData on MSN16h
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...
MedPage Today1d
FDA Warns About Anaphylaxis Risk With MS Drug
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...
The American Journal of Managed Care1d
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
HealthDay on MSN4h
Incidence, Prevalence of Peripartum Mental Illness Increased for Mothers With MS
Mothers with multiple sclerosis (MS) have an elevated incidence and prevalence of peripartum mental illness, accordi ...
Healthline10d
Multiple Sclerosis Progression and Your Life Expectancy
When it comes to the outlook for multiple sclerosis (MS), there’s both good news and bad news. Although MS isn’t fatal, there’s currently no cure — MS is a chronic condition. But many ...